Stockreport

Belite Bio, Inc (BLTE) Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease Transcript [Seeking Alpha]

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF Company Participants Nathan L. Mata - Chief Scientific Officer Hendrik Scholl - Chief Medical Officer Michel Michaelides Yu-Hsin Lin - Chairman of the Board of [Read more]